{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T05:25:17Z","timestamp":1699248317465},"reference-count":12,"publisher":"American Society of Consultant Pharmacists","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["sr care pharm"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:p>Patient is a 77-year-old female who is a retired teacher living with her husband. Patient presents to the clinic for a post-hospital discharge visit. She was treated for bacterial pneumonia with combination therapy of azithromycin and cefpodoxime. She was diagnosed with COPD seven years\n ago when she had to be treated for chronic dyspnea, cough, and sputum that kept her breathless and required hospitalization.<\/jats:p>","DOI":"10.4140\/tcp.n.2023.465","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:30:46Z","timestamp":1698366646000},"page":"465-471","source":"Crossref","is-referenced-by-count":0,"title":["Geriatric Pharmacotherapy Case Series: Chronic Obstructive Pulmonary Disease"],"prefix":"10.4140","volume":"38","author":[{"given":"Nadia","family":"Khartabil","sequence":"first","affiliation":[{"name":"West Coast University, School of Pharmacy, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","article-title":"Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary","volume":"207","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.rmed.2016.05.011","article-title":"Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability","volume":"116","year":"2016","journal-title":"Respir Med"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S2213-2600(21)00555-5","article-title":"Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan","volume":"10","year":"2022","journal-title":"Lancet Respir Med."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pupt.2017.06.002","article-title":"Withdrawal of inhaled corticosteroids in COPD: a meta-analysis","volume":"45","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"ref5","article-title":"Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study","volume":"6","year":"2020","journal-title":"ERJ Open Res"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1183\/09031936.00126814","article-title":"INSTEAD: a randomised switch trial of indacaterol versus salmeterol\/ fluticasone in moderate COPD","volume":"44","year":"2014","journal-title":"Eur Respir J"},{"issue":"23","key":"ref7","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","article-title":"Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD","volume":"374","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1465-9921-15-77","article-title":"Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)","volume":"15","year":"2014","journal-title":"Respir Res"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12931-017-0622-x","article-title":"Efficacy and safety of direct switch to indacaterol\/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial","volume":"18","year":"2017","journal-title":"Respir Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rmed.2017.02.007","article-title":"A two-year evaluation of the 'real life' impact of COPD on patients in Germany: the DACCORD observational study","volume":"124","year":"2017","journal-title":"Respir Med"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/rccm.201803-0405OC","article-title":"Long-term triple therapy de-escalation to indacaterol\/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind, triple-dummy clinical trial","volume":"198","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"ref12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa1407154","article-title":"Withdrawal of inhaled glucocorticoids and exacerbations of COPD","volume":"371","year":"2014","journal-title":"N Engl J Med"}],"container-title":["The Senior Care Pharmacist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ascp\/tscp\/2023\/00000038\/00000011\/art00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:30:41Z","timestamp":1699144241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.4140\/TCP.n.2023.465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"alternative-id":["2639-9636(20231101)38:11L.465;1-"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2023.465","relation":{},"ISSN":["2639-9636"],"issn-type":[{"value":"2639-9636","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}